← Back to dashboard
Intuitive Surgical
Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
Metric timing
This page mixes live market data, trailing fundamentals, and latest reported statement data.
Live / market snapshot
Price, 1D change, market cap, and enterprise value are current market-based figures.
TTM / forward
Most valuation and margin cards are trailing twelve months, while forward P/E uses forward consensus.
Latest quarter / dividend cadence
Balance-sheet ratios use the latest reported quarter. Dividend cadence is inferred from recent payout history.
latest annual revenue
latest quarterly revenue
latest annual profit
latest quarterly profit
annualized per share
latest ex-dividend cash amount
Latest headlines
Recent company headlines. Each link opens the original article in a new tab.
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Medtronic is deeply undervalued and a good bet for your portfolio. At the time, an uncertain growth outlook kept us from recommending the stock. Four months later, it’s time to retire the narrative of Medtronic as a perpetual laggard.
Why Deutsche Bank Still Isn’t Convinced About Intuitive Surgical (ISRG)With a short percentage of shares outstanding of 2.05%, Intuitive Surgical, Inc. (NASDAQ:ISRG) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 2, Deutsche Bank reduced its price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $366 from $440 while maintaining a Sell rating on the shares. The revised target reflects the firm’s updated valuation outlook for the […]
Did Leadership Shifts Amid FDA Scrutiny Just Reframe Intuitive Surgical's (ISRG) Investment Narrative?In late May, Intuitive Surgical announced leadership changes effective July 1, promoting nearly 20-year company veteran Taylor Patton to Chief Commercial and Marketing Officer while moving current CCMO Henry Charlton into a new Senior Vice President of Global Business Operations role focused on global value generation. These executive moves come as Intuitive manages FDA safety alerts, product recalls, and rising competition, all while relying on its large installed da Vinci base and...
Intuitive Surgical (ISRG) Stock After 28% Slide Are Valuation Expectations Reset EnoughIf you are wondering whether Intuitive Surgical stock is starting to offer better value or still pricing in a lot of optimism, you are not alone. The share price closed at US$406.78, with returns declining 2.3% over the past week, 7.1% over the past month, and 27.6% year to date. The return over the past 1 year is down 21.0% and the 3 and 5 year returns are 25.1% and 33.7% respectively. Recent coverage has focused on how Intuitive Surgical sits within medical technology and minimally...
Intuitive Surgical (ISRG) Stock Could Be 23.6% Undervalued After Recent Share Price WeaknessIntuitive Surgical (ISRG) is back in focus after recent trading data showed the stock down about 7% over the past month and around 14% over the past 3 months, sharpening attention on its long term track record. See our latest analysis for Intuitive Surgical. At a share price of $406.78, Intuitive Surgical’s recent 1 month share price return of about 7% down and year to date share price return of about 28% down point to fading short term momentum, even though the 3 year total shareholder...
This Healthcare Stock Trades at a Richer Valuation Than Nvidia. Could It Also Deliver Bigger Long-Term Returns?Artificial intelligence is changing the world, but this healthcare technology is quietly doing the same.
Why it could benefit going forward
- Intuitive is the dominant public surgical robotics franchise and belongs in any serious robotics basket.
- Its installed base, procedure growth, and recurring instruments model create a stronger moat than most robotics names.
- This adds a high-quality medical robotics angle that is less tied to data-center spending or industrial cycles.
Moat / edge
- Large installed base and deep surgeon training ecosystem.
- Recurring revenue from instruments, accessories, and service.
- Years of lead time and brand strength in robotic-assisted surgery.
What to watch
- Procedure growth and system placements.
- Adoption of newer da Vinci platforms and adjacent products.
- Gross-margin resilience as the business scales.
Key risks
- Premium valuation can leave less room for execution misses.
- Hospital capital-spending cycles still matter.
Business snapshot
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.